Sartorius Stedim Biotech SA (SDMHF)
229.00
+11.91
(+5.49%)
USD |
OTCM |
Aug 28, 16:00
Sartorius Stedim Biotech Price to Book Value : 4.600 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 4.600 |
| August 27, 2026 | 4.360 |
| August 26, 2026 | 4.360 |
| August 25, 2026 | 4.360 |
| August 24, 2026 | 4.360 |
| August 21, 2026 | 4.360 |
| August 20, 2026 | 4.360 |
| August 19, 2026 | 4.360 |
| August 18, 2026 | 4.360 |
| August 17, 2026 | 4.188 |
| August 14, 2026 | 4.188 |
| August 13, 2026 | 4.039 |
| August 12, 2026 | 4.168 |
| August 11, 2026 | 4.057 |
| August 10, 2026 | 4.057 |
| August 07, 2026 | 4.057 |
| August 06, 2026 | 4.057 |
| August 05, 2026 | 4.037 |
| August 04, 2026 | 4.037 |
| August 03, 2026 | 4.037 |
| July 31, 2026 | 3.877 |
| July 30, 2026 | 3.877 |
| July 29, 2026 | 3.877 |
| July 28, 2026 | 3.877 |
| July 27, 2026 | 3.877 |
| Date | Value |
|---|---|
| July 24, 2026 | 3.877 |
| July 23, 2026 | 3.856 |
| July 22, 2026 | 3.846 |
| July 21, 2026 | 3.846 |
| July 20, 2026 | 4.328 |
| July 17, 2026 | 4.328 |
| July 16, 2026 | 4.328 |
| July 15, 2026 | 4.328 |
| July 14, 2026 | 4.328 |
| July 13, 2026 | 4.328 |
| July 10, 2026 | 4.234 |
| July 09, 2026 | 4.037 |
| July 08, 2026 | 4.037 |
| July 07, 2026 | 4.130 |
| July 06, 2026 | 4.130 |
| July 02, 2026 | 4.306 |
| July 01, 2026 | 4.018 |
| June 30, 2026 | 4.018 |
| June 29, 2026 | 4.191 |
| June 26, 2026 | 4.104 |
| June 25, 2026 | 4.104 |
| June 24, 2026 | 3.923 |
| June 23, 2026 | 3.829 |
| June 22, 2026 | 3.742 |
| June 18, 2026 | 3.946 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agilent Technologies, Inc. | 5.891 |
| Bio-Rad Laboratories, Inc. | 1.445 |
| Bruker Corp. | 3.652 |
| Azenta, Inc. | 0.9549 |
| Danaher Corp. | 2.888 |
Price to Book Value Related Metrics
| PE Ratio | 65.29 |
| PS Ratio | 6.358 |
| PEG Ratio | 1.648 |
| Price to Free Cash Flow | 85.85 |
| Price | 229.00 |
| Earnings Yield | 1.53% |
| Market Cap | 22.28B |
| PEGY Ratio | 1.634 |
| Operating PE Ratio | 34.21 |
| Normalized PE Ratio | 55.94 |